Going Viral Archives - Page 4 of 5

Working in a ‘COVID-19 business as usual’ environment – A pragmatic approach

COVID-19 is now endemic, constantly changing and evolving. The health system is under rising pressure at all points, and therefore a concerted approach to prevent and minimize disease is increasingly needed

Critical perspectives on the current Australian COVID response, Monkeypox and a few other things

Transitioning our patients to Novavax and protein-based vaccines and away from mRNA. Monkeypox should be taken seriously... especially for high-risk patients

Influenza Update for 2022

Some ‘basic’ influenza epidemiology, what happened in 2021 and what to expect in 2022, what's new with cell culture influenza vaccines and high dose influenza vaccines, and importance of vaccination rates

COVID Update – Variants, long COVID and safety of boosters

Current burden and variants, long COVID and vaccines, and COVID vaccine boosters - effectiveness and safety and the need for a 4th dose

COVID Update – New advice, Coronary concern, Ba5

New advice on when to vaccinate after COVID infection

COVID update – Ba4 and Ba5, boosters, antivirals, long COVID

Should GPs have a fourth booster? The Ba4 and Ba5 variants, more information on the antivirals, long COVID is an emerging public health issue.

COVID Update – Epidemiology, boosters, antivirals, future

A look at our local and national infection rates- what does the medium to long term future look like?

COVID Update – Fourth jab, Ba2 update, flurona, antivirals

Ba2, Deltacron, Omicron and other variants- the winter booster - for which patients? An update on the other vaccines and the COVID antivirals.

COVID variants, antivirals, vaccines & vaccine hesitancy

Overseas travel and COVID - booster before travelling? What’s the evidence? The more transmissible OMICRON subvariant... is there any cause for concern here?

COVID and the Brain

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

COVID Update – ATAGI, Fourth booster, Novavax, Post-COVID heart risk

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

COPD, COVID and other jabs

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Going Viral

Working in a ‘COVID-19 business as usual’ environment – A pragmatic approach

COVID-19 is now endemic, constantly changing and evolving. The health system is under rising pressure at all points, and therefore a concerted approach to prevent and minimize disease is increasingly needed

Critical perspectives on the current Australian COVID response, Monkeypox and a few other things

Transitioning our patients to Novavax and protein-based vaccines and away from mRNA. Monkeypox should be taken seriously... especially for high-risk patients

Influenza Update for 2022

Some ‘basic’ influenza epidemiology, what happened in 2021 and what to expect in 2022, what's new with cell culture influenza vaccines and high dose influenza vaccines, and importance of vaccination rates

COVID Update – Variants, long COVID and safety of boosters

Current burden and variants, long COVID and vaccines, and COVID vaccine boosters - effectiveness and safety and the need for a 4th dose

COVID Update – New advice, Coronary concern, Ba5

New advice on when to vaccinate after COVID infection

COVID update – Ba4 and Ba5, boosters, antivirals, long COVID

Should GPs have a fourth booster? The Ba4 and Ba5 variants, more information on the antivirals, long COVID is an emerging public health issue.

COVID Update – Epidemiology, boosters, antivirals, future

A look at our local and national infection rates- what does the medium to long term future look like?

COVID Update – Fourth jab, Ba2 update, flurona, antivirals

Ba2, Deltacron, Omicron and other variants- the winter booster - for which patients? An update on the other vaccines and the COVID antivirals.

COVID variants, antivirals, vaccines & vaccine hesitancy

Overseas travel and COVID - booster before travelling? What’s the evidence? The more transmissible OMICRON subvariant... is there any cause for concern here?

COVID and the Brain

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

COVID Update – ATAGI, Fourth booster, Novavax, Post-COVID heart risk

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

COPD, COVID and other jabs

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Get the app

Site

Company

Connect

Legal

Healthed

Going Viral

COVID-19 is now endemic, constantly changing and evolving. The health system is under rising pressure at all points, and therefore a concerted approach to prevent and minimize disease is increasingly needed

Transitioning our patients to Novavax and protein-based vaccines and away from mRNA. Monkeypox should be taken seriously... especially for high-risk patients

Some ‘basic’ influenza epidemiology, what happened in 2021 and what to expect in 2022, what's new with cell culture influenza vaccines and high dose influenza vaccines, and importance of vaccination rates

Current burden and variants, long COVID and vaccines, and COVID vaccine boosters - effectiveness and safety and the need for a 4th dose

New advice on when to vaccinate after COVID infection

Should GPs have a fourth booster? The Ba4 and Ba5 variants, more information on the antivirals, long COVID is an emerging public health issue.

A look at our local and national infection rates- what does the medium to long term future look like?

Ba2, Deltacron, Omicron and other variants- the winter booster - for which patients? An update on the other vaccines and the COVID antivirals.

Overseas travel and COVID - booster before travelling? What’s the evidence? The more transmissible OMICRON subvariant... is there any cause for concern here?

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Get the app

Site

Company

Connect

Legal

Extra Details

Healthed